New drug could combat killer diseases

September 30, 2011

(Medical Xpress) -- Researchers from the University of Reading have developed a new drug which could reduce the spread of deadly diseases such as Lassa Fever and Aseptic Meningitis.

Dr Ben Neuman, in collaboration with labs in California and Oregon and AVI Biopharma of Corvallis Oregon, has designed a drug which reduces the spread of infection of a family of viruses known as arenaviruses by up to 90% in .

Arenaviruses are normally found in , such as rodents and bats. People can become infected after coming into contact with infected rodents that live in and around their homes.

Common in Africa, South America and North America these viruses can be fatal. The Centre for Disease Control estimates that arenavirus diseases, such as Lassa Fever, kill an estimated 5,000 people each year, mostly in the . New types of arenaviruses are being discovered at the rate of about one per year.

reproduce in living cells. When the virus has made enough copies of itself it leaves the to infect other cells. The

The video will load shortly.
interview with Ben Neuman
new drugs developed by Dr Neuman's group, called PPMO, work by stopping the virus from copying its own genes, thereby stopping the disease from spreading.

Dr Neuman, from the University of Reading's School of Biological Sciences, showed that three related PPMO compounds could prevent the spread of infection from cells which were infected by four different viruses of the arenavirus family. The compounds were found to reduce the amount of virus present in the liver by over 90% following treatment.

Dr Neuman said: "The results we have so far are very promising. Cells will naturally die and be replaced relatively regularly in the body, so if the stop the viruses from reproducing, potentially the virus could eventually be eradicated from the body over time.

"But arenavirus PPMO are not a finished product yet. Before they can be approved for medical use, more work will be needed to show that they are safe and effective in larger animals and people."

If successful PPMO could be used as part of a multi-drug therapy, a strategy which is used to slow the spread of HIV and its progression to AIDS. It is also thought that PPMO could one day be given as a preventative measure to people who will be travelling to places where arenavirus infections are common.

PPMO compounds are also being developed to combat swine flu and other potentially such as Dengue fever and Ebola haemorrhagic fever.

Dr Neuman's research is detailed in his study entitled Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors published today, Fri 30 Sept 2011, in the journal Antimicrobial Agents and Chemotherapy.

Related Stories

Recommended for you

Link between cells associated with aging and bone loss

August 21, 2017
Mayo Clinic researchers have reported a causal link between senescent cells - the cells associated with aging and age-related disease - and bone loss in mice. Targeting these cells led to an increase in bone mass and strength. ...

Gut microbes may talk to the brain through cortisol

August 21, 2017
Gut microbes have been in the news a lot lately. Recent studies show they can influence human health, behavior, and certain neurological disorders, such as autism. But just how do they communicate with the brain? Results ...

Make way for hemoglobin

August 18, 2017
Every cell in the body, whether skin or muscle or brain, starts out as a generic cell that acquires its unique characteristics after undergoing a process of specialization. Nowhere is this process more dramatic than it is ...

Bio-inspired materials give boost to regenerative medicine

August 18, 2017
What if one day, we could teach our bodies to self-heal like a lizard's tail, and make severe injury or disease no more threatening than a paper cut?

Are stem cells the link between bacteria and cancer?

August 17, 2017
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease. The main cause of this cancer is the bacterium Helicobacter pylori, ...

Two-step process leads to cell immortalization and cancer

August 17, 2017
A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.